CD19 and hepatocellular carcinoma: Additionally, two other B cell subsets (CD27+IgD+ NSw MBCs and CD19+B220+CD138+ PBs) were found in MASLD and HCC tissues, which might also play a protumorigenic role in liver disease progression.